Varicella Zoster Virus Archives - Infectious Disease Advisor

General Infectious Disease

Shingrix Approved to Prevent Shingles in Immunocompromised Adults

By

Brian Park, PharmD

July 30, 2021

Previously, the vaccine was only approved for adults 50 years of age and older.

Pediatric Illnesses

Universal Vaccination Program Corresponds to Decrease in Overall Pediatric Herpes Zoster Cases

By

Bradley van Paridon

July 29, 2021

Investigators sought to assess the impact of age and vaccination status on rates of herpes zoster in a pediatric population.

Prevention

2008 to 2018 Saw Increase in Shingles Vaccination in Over 60s

July 15, 2020

From 2008 to 2018, there was an increase in shingles vaccination among adults aged 60 years and older, with demographic, socioeconomic, and geographic variations in vaccination rates.

Diagnostics

Initial Presentation Not Associated With Pathogen in Infectious Encephalitis

By

Bradley van Paridon

June 16, 2020

A team of French investigators sought to identify factors that could be considered predictive of the etiology of infectious encephalitis.

Pediatric Illnesses

Herpes Zoster in Healthy Children Linked to Varicella-Zoster Vaccination

By

Steve Duffy

April 16, 2018

The morphology of the lesions included erythematous papules, pseudovesicles, and plaques, with associated pain in 2 and pruritus in 3 patients; systemic symptoms ranged from none to low‐grade fevers, upper respiratory symptoms, and joint pain.

Prevention

Vaccine Lessens Incidence of Herpes Zoster Complications in Immuncompetent Older Adults

By

Zahra Masoud

April 6, 2018

Researchers reviewed clinical trial data to evaluate the efficacy of herpes zoster subunit vaccine in preventing complications, hospitalizations, and deaths.

Prevention

ACIP: New Recommendations for Herpes Zoster Vaccine Administration

By

Anna Olechowska

February 22, 2018

The Advisory Committee on Immunization Practices has provided 3 new recommendations to supplement its original 2008 report, as well as a cost-effectiveness analysis from the CDC.

Skin Infections

VZV Vaccine Promising in Immunocompromised Patients With Herpes Zoster

By

Steve Duffy

March 8, 2017

Phase 3 study looked at the safety, tolerability, efficacy, and immunogenicity of inactivated VZV Vaccine in recipients of auto-HSCT.

Skin Infections

Increased Risk of Stroke With Incident Herpes Zoster in Autoimmune Disease

By

Corinna Panlilio Sison, MD

September 15, 2016

Strategies to decreased risk of contracting varicella zoster virus need to be addressed in particularly susceptible populations, like those with autoimmune disease.